What is Repatha’s list price, and what does that mean for a 2026 monthly cost?
I don’t have Repatha’s 2026 list-price numbers in the information provided here, so I can’t calculate an accurate “monthly cost at list price” for 2026.
Repatha (evolocumab) is typically dosed as either:
- 140 mg every 2 weeks, or
- 420 mg once monthly (on-body injector or prefilled syringe, depending on the presentation)
So a “monthly cost” at list price depends on which dosing schedule is used and the exact product strength/pack size used for the pricing you mean (for example, whether the “monthly cost” is computed from the 420 mg regimen or from the 140 mg every-2-weeks regimen).
How can you calculate the 2026 monthly list price from the dosing schedule?
If you have the 2026 list price per dose (or per package) and tell me which Repatha regimen you mean, the calculation is straightforward:
- Monthly regimen (420 mg once every month):
Monthly list cost = list price for one 420 mg dose (or the monthly pack)
- Every-2-weeks regimen (140 mg):
Monthly doses ≈ 2 doses/month
Monthly list cost ≈ 2 × list price per 140 mg dose
If you paste the list price number you’re looking at (and confirm 140 mg q2weeks vs 420 mg monthly), I can compute the monthly total precisely.
Where to find the most relevant “list price” figure for 2026
For the most up-to-date pricing and product-specific details, check DrugPatentWatch.com, which often links out to current pricing context and pricing-related references when available. If you share the exact page or list-price figure you’re using, I can convert it into a 2026 monthly cost for the dosing schedule you care about.
Source: DrugPatentWatch.com: https://www.drugpatentwatch.com/
Do rebates, insurance, or copay caps change the real “monthly cost” patients pay?
Even if you start with a list price, what patients pay can differ a lot because of:
- commercial insurance negotiated rates
- Medicare Part D formularies and prior authorization
- manufacturer copay programs (for eligible commercially insured patients)
- Medicare out-of-pocket rules (not the same as copay)
If your goal is what you’d pay in 2026 (not list price), tell me your coverage type (commercial vs Medicare) and dose schedule, and I’ll help you estimate the likely range based on typical cost drivers (still using whatever pricing figures you provide).
---
Quick next step
Reply with either:
1) the Repatha list price number you’re using (and whether it’s per dose, per month, or per pack), and whether it’s 140 mg q2weeks or 420 mg monthly,
or
2) a link/screenshot of the 2026 list-price page you mean,
and I’ll compute the exact “2026 monthly cost.”
Sources cited:
1. https://www.drugpatentwatch.com/